Makrósýklískt karboxýlsýru- og asýlsúlfónamíðefnasamband sem hindri á lifrabólgu C eftirmyndun

The present application provides compounds of the general formulas I-IX as defined herein, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The present application further provides treatment methods, including methods of treating a hepatitis C virus infe...

Full description

Saved in:
Bibliographic Details
Main Authors LAWRENCE M. BLATT, YUTONG JIANG, GEORGE ANDREW DOHERTY, STEVEN WADE ANDREWS, MACHENDER R. MADDURU, JOHN ANTHONY JOSEY, KEVIN RONALD CONDROSKI, SCOTT D. SEIWERT, APRIL LAYNE KENNEDY, STEVEN MARK WENGLOWSKY, BENJAMIN T. WOODARD, PETER JOHN STENGEL
Format Patent
LanguageIcelandic
Published 15.04.2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present application provides compounds of the general formulas I-IX as defined herein, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The present application further provides treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
Bibliography:Application Number: IS20060008395